Physician profile
Muhammad H Arshad
NPI 1548746183
$2,180.02
in general payments reported to CMS, 2019-2025
19 companies · $551 in 2025
The $551 reported for 2025 was more than what 91% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.40 · 2022: $766 · 2023: $338 · 2024: $494 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $479.68 | 2022-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $390.74 | 2022-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $308.16 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $260.37 | 2022-2025 | |
| Novo Nordisk INC | $137.07 | 2023-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $116.02 | 2025 | |
| Gilead Sciences, INC. | $97.04 | 2022-2023 | |
| Ceribell, INC. | $90.42 | 2023-2025 | Pocket Eeg Device, Ceribell Rapid Response Eeg |
| Kestra Medical Technology Services, INC. | $80.39 | 2025 | Assure Wcd |
| Scpharmaceuticals INC. | $33.10 | 2024-2025 | |
| Ucb, INC. | $30.91 | 2025 | Briviact |
| Otsuka America Pharmaceutical, INC. | $26.93 | 2025 | Jynarque |
| Eisai INC. | $21.77 | 2022 | |
| Merck Sharp & Dohme LLC | $21.18 | 2023 | Dificid, Zerbaxa |
| Ferring Pharmaceuticals INC. | $19.68 | 2023 | Rebyota |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.32 | 2025 | Uplizna |
| Smith+Nephew, INC. | $18.77 | 2025 | Collagenase Santyl |
| W. L. Gore & Associates, INC. | $14.83 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $13.64 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Arshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.